TrialBMJ open2016

Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial.

Kam Wa Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.